Go to the list of all blogs
Allana's Avatar
published in Blogs
Sep 25, 2026
SRTY vs TZA: Comparing Two -3x Inverse Russell 2000 ETFs

SRTY vs TZA: Comparing Two -3x Inverse Russell 2000 ETFs

Key Takeaways

  • Both SRTY and TZA aim for daily results equal to three times the inverse (-3x) of the Russell 2000 Index, positioning them as structurally similar leveraged inverse ETFs suited mainly for short-term tactical applications.
  • SRTY features a net expense ratio of 0.95%, a modest edge over TZA’s 0.99%, which could matter for longer tactical holds.
  • Each fund relies on synthetic exposure via swaps, futures, and cash equivalents instead of direct stock ownership, leading to limited traditional diversification and notable sensitivity to daily compounding.
  • The underlying Russell 2000 Index focuses on U.S. small-cap companies, with key sector weights in health care (around 20%), financials (around 18%), and industrials (around 15%).
  • Liquidity levels are adequate for both products, supporting use by institutional and retail investors looking for short-term inverse small-cap exposure.
  • These ETFs provide amplified downside participation distinct from long-only small-cap vehicles, yet they require active monitoring and are not designed for multi-day holds without oversight due to volatility decay.

Why These ETFs Stand Out

ProShares UltraPro Short Russell2000 (SRTY) and Direxion Daily Small Cap Bear 3X ETF (TZA) offer closely matched choices for investors seeking leveraged inverse exposure to U.S. small-cap equities. Instead of competing with traditional long-only small-cap funds, these products support hedging strategies or bearish outlooks on the Russell 2000 Index. Their similar structures make them worth comparing when small-cap volatility or sector shifts affect positioning and risk decisions.

An Overview of SRTY

SRTY targets daily results, before fees and expenses, that correspond to three times the inverse (-3x) of the Russell 2000 Index’s daily performance. It uses a synthetic approach built on swaps, futures contracts, and cash equivalents, resulting in a portfolio of roughly 10–15 holdings centered on these instruments. Sector exposures track the benchmark, with emphasis on health care, financials, and industrials. The net expense ratio is 0.95%. As a passive vehicle with daily rebalancing, SRTY resets its exposure each trading day, setting it apart from unleveraged or long-only small-cap options. I also checked this using Tickeron’s AI Screener to see how the ETF compares to others in the category.

An Overview of TZA

TZA follows the same primary goal: daily investment results, before fees and expenses, equal to three times the inverse (-3x) of the Russell 2000 Index. It similarly depends on swaps, futures, and cash instruments, producing a compact portfolio of about 12 holdings. Sector allocations track the small-cap benchmark closely, led by health care, financials, and industrials. The net expense ratio stands at 0.99%. Daily rebalancing keeps the leveraged inverse target intact, framing the fund as a tactical instrument in the inverse equity space.

The Russell 2000 Context

The Russell 2000 Index includes roughly 2,000 U.S. small-capitalization companies across varied sectors, with meaningful allocations to health care, financials, and industrials. Factors such as interest rate expectations, economic growth paths, and credit conditions often shape small-cap cycles. Regulatory changes in lending, healthcare, or energy can act as triggers, while earnings variability and liquidity issues represent ongoing risks in this segment. Flows into or out of small-cap equities tend to reflect broader risk appetite and rotation trends over market cycles.

Performance and Positioning Insights

Across recent market cycles, both SRTY and TZA have shown the amplified volatility expected from their -3x daily objectives, with returns drifting from the index over multi-day periods because of compounding effects. Relative positioning reveals small cost differences, where SRTY’s lower expense ratio may offer a slight efficiency benefit during sustained inverse exposure. Volatility levels stay comparable given matching leverage and benchmark focus, although liquidity nuances can affect execution during busy trading sessions. Sector trends within the Russell 2000, particularly in healthcare and financials, continue to shape performance for both products over longer horizons.

How I Use Tickeron’s AI Screener

In my research process, I often turn to Tickeron’s AI Screener to filter ETFs and stocks by technical patterns, fundamentals, trends, and volatility signals. It allows quick scans across thousands of securities with customizable criteria like industry, market cap, and performance metrics, helping surface relevant ideas more efficiently than manual review. This tool has proven useful when evaluating inverse products like these for short-term positioning.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SRTY, TZA

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


SRTY's RSI Indicator peaks and leaves overbought zone

The 10-day RSI Oscillator for SRTY moved out of overbought territory on October 02, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 instances where the indicator moved out of the overbought zone. In 25 of the 25 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 53 of 56 cases where SRTY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for SRTY turned negative on October 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 42 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRTY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

SRTY broke above its upper Bollinger Band on September 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

SRTY moved above its 50-day moving average on August 28, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SRTY crossed bullishly above the 50-day moving average on September 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 85%.

Following a +2.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where SRTY advanced for three days, in 242 of 266 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

The Aroon Indicator entered an Uptrend today. In 159 of 175 cases where SRTY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Industry description

The investment seeks daily investment results that correspond to three times the inverse (-3x) of the daily performance of the Russell 2000® Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is a measure of small-cap U.S. stock market performance. Under normal circumstances, the fund will obtain inverse leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.
View a ticker or compare two or three
SRTY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Inverse Equity
Address
ProShares Trust7501 Wisconsin Avenue,Suite 1000Bethesda
Phone
N/A
Web
www.proshares.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.
I've always appreciated how Mastercard (MA) maintains a commanding position in the global payments industry, processing transactions across 3.4 billion cards at 150 million merchant locations worldwide. The network effects here create a formidable moat—increased adoption by issuers, acquirers, and consumers just reinforces its dominance. What stands out to me is how Mastercard is evolving beyond a pure processor into a services-first platform. Value-added services (VAS)—covering cybersecurity, data analytics, and consulting—are now approaching 40% of revenues and growing at double the rate of traditional payments.
MU shares are declining approximately -6.00% in premarket trading on April 2, 2026, pulling back to roughly $353.70 from the prior session's close of $376.27. The primary catalyst is a sweeping new round of tariff announcements from the Trump administration, dubbed by markets as "Liberation Day 2.0," which has sparked a broad risk-off selloff across technology and semiconductor stocks
Shares of Robinhood Markets are down approximately 6.15% in Thursday's intraday session, trading around $65.80 after closing at $70.11 on April 1, 2026. Wolfe Research delivered a sharp blow by cutting its price target on HOOD by 30%, citing persistent weakness in crypto trading volumes as a core drag on revenue.
Shares of Iridium Communications (IRDM) surged approximately +11.00% in Thursday's session, rising from a prior close of $28.52 to an intraday high near $31.76. A broad-based equity market rally drove significant gains across communication and satellite sector stocks, as investor sentiment sharply reversed after days of macro-driven selling pressure tied to tariff fears.
AirSculpt Technologies, Inc. (AIRS) stands out as a leading provider of minimally invasive body contouring procedures through its Elite Body Sculpture brand. The company specializes in proprietary AirSculpt treatments that remove fat and tighten skin without general anesthesia. These include options like AirSculpt+, AirSculpt Smooth for cellulite reduction, and specialized fat transfer procedures such as Power BBL for Brazilian butt lifts, Up a Cup for breast enhancement, and Hip Flip for hourglass contouring. Based in Miami Beach, Florida, and founded in 2012, AIRS operates centers across the United States, Canada, and the United Kingdom.
ASRT stock surged +66% over the past 30 days, driven by strong Q4 2025 earnings beat and optimistic 2026 guidance highlighting Rolvedon growth. Over the past quarter, the stock rose +117%, fueled by improving gross margins, stable product demand, and analyst price target increases.